Literature DB >> 30029583

Epidemiology of RSV and hMPV in Belgium: a 10-year follow-up.

Lien Cattoir1, Anne Vankeerberghen1, An Boel1, Kristien Van Vaerenbergh1, Hans De Beenhouwer1.   

Abstract

Objectives: Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are important respiratory pathogens. Both viral pathogens have similar clinical manifestations. The epidemiology of RSV is well known, that of hMPV is less clear. We reviewed the results of 10 consecutive years of molecular testing for RSV and hMPV in respiratory samples of Flemish patients.
Methods: In the laboratory of the OLV hospital Aalst, Belgium, multiplex RT-PCR assays are used for the detection of RSV and hMPV. The lab receives invasive and noninvasive respiratory samples of patients from all over Flanders.
Results: Between September 2006 and August 2016, 16,826 respiratory samples were analyzed for RSV and hMPV. Of these samples, 18% tested positive for RSV and 7.3% for hMPV. RSV consistently peaked in November/December each year within a very narrow time frame. The occurrence of hMPV was less predictable and spreaded more widely throughout the winter and spring. Both viruses were mainly found in samples from young children. RSV was most frequently detected in samples from infants <3 months, while hMPV peaked between 6 and 9 months. After the age of 1 year, RSV rapidly dropped. hMPV dropped a little later and slower. Both viruses slightly increased again at older age (>50 years). Conclusions: Despite their similarities, some of the epidemiologic characteristics of hMPV and RSV differ. The most striking difference is the annual distribution of RSV and hMPV infections.

Entities:  

Keywords:  Belgium; Human metapneumovirus; epidemiology; respiratory syncytial virus

Mesh:

Year:  2018        PMID: 30029583     DOI: 10.1080/17843286.2018.1492509

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  8 in total

1.  Risk factors for disease severity and increased medical resource utilization in respiratory syncytial virus (+) hospitalized children: A descriptive study conducted in four Belgian hospitals.

Authors:  Marijke Proesmans; Annabel Rector; Els Keyaerts; Yannick Vandendijck; Francois Vermeulen; Kate Sauer; Marijke Reynders; Ann Verschelde; Wim Laffut; Kristien Garmyn; Roman Fleischhackl; Jacques Bollekens; Gabriela Ispas
Journal:  PLoS One       Date:  2022-06-06       Impact factor: 3.752

Review 2.  HMPV in Immunocompromised Patients: Frequency and Severity in Pediatric Oncology Patients.

Authors:  Cesar Martinez-Rodriguez; Ma Del Rocio Banos-Lara
Journal:  Pathogens       Date:  2020-01-10

3.  Experiments Investigating the Competitive Growth Advantage of Two Different Genotypes of Human Metapneumovirus: Implications for the Alternation of Genotype Prevalence.

Authors:  Zhen Zhou; Pan Zhang; Yuxia Cui; Yongbo Zhang; Xian Qin; Rongpei Li; Ping Liu; Ying Dou; Lijia Wang; Yao Zhao
Journal:  Sci Rep       Date:  2020-02-18       Impact factor: 4.379

4.  Viral etiology and epidemiology of pediatric patients hospitalized for acute respiratory tract infections in Macao: a retrospective study from 2014 to 2017.

Authors:  Cheng Lei; Lisong Yang; Cheong Tat Lou; Fan Yang; Kin Ian SiTou; Hao Hu; King Io; Kun Tat Cheok; Baoquan Pan; Carolina Oi Lam Ung
Journal:  BMC Infect Dis       Date:  2021-03-26       Impact factor: 3.090

5.  Burden of respiratory syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018.

Authors:  Marco Heppe-Montero; Stefan Walter; Valentín Hernández-Barrera; Ruth Gil-Prieto; Ángel Gil-de-Miguel
Journal:  BMC Infect Dis       Date:  2022-03-31       Impact factor: 3.090

6.  Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand.

Authors:  Puneyavee Aikphaibul; Tuangtip Theerawit; Jiratchaya Sophonphan; Noppadol Wacharachaisurapol; Nattapong Jitrungruengnij; Thanyawee Puthanakit
Journal:  Influenza Other Respir Viruses       Date:  2020-08-12       Impact factor: 4.380

7.  Prevalence and Risk Factors of Respiratory Syncytial Virus in Children under 5 Years of Age in the WHO European Region: A Systematic Review and Meta-Analysis.

Authors:  Nora Suleiman-Martos; Alberto Caballero-Vázquez; Jose Luis Gómez-Urquiza; Luis Albendín-García; Jose Luis Romero-Béjar; Guillermo A Cañadas-De la Fuente
Journal:  J Pers Med       Date:  2021-05-15

8.  Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017.

Authors:  Marco Heppe Montero; Ruth Gil-Prieto; Stefan Walter; Fernando Aleixandre Blanquer; Ángel Gil De Miguel
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.